Home › News › Market

LOTTE Biologics Secures Commercial Manufacturing Agreement for Songdo Plant 1

LOTTE Biologics Secures Commercial Manufacturing Agreement for Songdo Plant 1

LOTTE Biologics has signed a commercial manufacturing agreement with a global pharmaceutical company, marking the first major commercial manufacturing commitment for its Songdo Plant 1 in South Korea ahead of the facility's operational launch.

Under the agreement, the company will provide integrated drug substance and drug product manufacturing services for key products in the customer's portfolio. Commercial production is expected to begin in 2027.

The Songdo Bio Campus is being developed with a planned manufacturing capacity of 360,000 litres across three plants. Songdo Plant 1 will have a capacity of 120,000 litres, comprising eight 15,000-litre stainless-steel bioreactors. The facility will feature advanced production infrastructure, automation and cold-chain warehousing.

The new facility will complement LOTTE Biologics' Syracuse Bio Campus in New York, which has more than 20 years of manufacturing experience and a track record supporting over 62 regulatory approvals. Together, the two campuses will form an integrated manufacturing network supporting global biologics production and supply chain operations.

James Park, Co-CEO of LOTTE Biologics, said the agreement reflected customer confidence in the company's manufacturing capabilities and strategy to develop a globally integrated biologics manufacturing platform.

The agreement marks a commercial milestone for LOTTE Biologics as it prepares to expand its Contract Development and Manufacturing Organisation (CDMO) operations through the Songdo facility.

More news about: market | Published by News Bureau | November - 18 - 2026

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members